Health Catalyst agrees to sell Vitalware to Med-Metrix for $147 million cash

Health Catalyst

Health Catalyst

HCAT

0.00
  • Health Catalyst agreed to sell its Vitalware mid-revenue cycle unit to Med-Metrix for USD 147 million in cash.
  • Proceeds are expected to bolster the balance sheet, supporting core technology and AI investment priorities.
  • Net proceeds, combined with cash on hand, are slated to repay and terminate a senior secured term loan with about USD 160 million outstanding.
  • Vitalware generated about USD 37 million in fiscal 2025 revenue, providing software for health system financial operations.
  • The deal is expected to close in 2026, subject to customary closing conditions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Health Catalyst Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606040903PRIMZONEFULLFEED9731925) on June 04, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.